Theriva Biologics, Inc. TOVX
Set alert
0.18 USD +0.01 +7.92%
At close · Nov 2
0.20 +0.01 +5.98%
After hours · Nov 2, 7:59 PM ET
0.1361 Day range 0.1904
0.17 52-week range 0.41
- YTD
- -12.38%
- 1 year
- -40.65%
- Open
- 0.15
- Prev close
- 0.1705
- Mkt cap
- 8.44M
- Vol
- 91.20M
- Avg vol
- 520.48K
- EPS
- 0.73
- P/E
- 0.25
- Div yield
- 0.00%
More statistics
- Low
- 0.1361
- High
- 0.1904
- Forward P/E
- -0.07
- Beta
- 1.34
- Short ratio
- 0.03
- Inst. own
- 21.21%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.44
- 200-d avg
- 5.63
- 1y target
- 90.50
5D chart
Signals (131)
| Name | Time | Ago |
|---|---|---|
| RSI: Overbought | Nov 2, 3:55 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 3:00 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 2:45 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 2:20 PM | 13 hours ago |
| SMA: Bearish | Nov 2, 2:15 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 2:05 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 2:05 PM | 13 hours ago |
| MACD: Buy Signal | Nov 2, 2:05 PM | 13 hours ago |
| MACD: Sell Signal | Nov 2, 2:00 PM | 13 hours ago |
| SMA: Bearish | Nov 2, 1:45 PM | 14 hours ago |
| MACD: Buy Signal | Nov 2, 1:40 PM | 14 hours ago |
| SMA: Bullish | Nov 2, 1:20 PM | 14 hours ago |
| SMA: Bearish | Nov 2, 12:40 PM | 15 hours ago |
| MACD: Sell Signal | Nov 2, 12:25 PM | 15 hours ago |
| SMA: Bearish | Nov 2, 12:10 PM | 15 hours ago |
| SMA: Bullish | Nov 2, 11:25 AM | 16 hours ago |
| SMA: Bearish | Nov 2, 11:20 AM | 16 hours ago |
| SMA: Bullish | Nov 2, 11:15 AM | 16 hours ago |
| SMA: Bearish | Nov 2, 11:10 AM | 16 hours ago |
| SMA: Bullish | Nov 2, 11:00 AM | 16 hours ago |
Newest 20 of 131.
Analyst view
Consensus: none
Price target (mean) 90.50 +49084.8% upside
Now 0.184
- Target (low)
- 6.00
- Target (mean)
- 90.50
- Target (high)
- 175.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -5.50 | -5.50 – -5.50 | -8.25 | +33.3% | 0 | 0.0% | 1 |
| Next quarter | 0.00 | 0.00 – 0.00 | -7.50 | 0.0% | 0 | 0.0% | 0 |
| Current year | -23.75 | -23.75 – -23.75 | -28.50 | +16.7% | 0 | 0.0% | 1 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 13, 2024 | Maxim Group | Maintained | Buy | Buy |